13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

Page 9 of 10

Page 9 of 10 – SEC Filing

(2)      Deerfield
Management

Sole power to vote or direct the vote:
0

Shared power to vote or direct the vote:
8,571,739

Sole power to dispose or to direct the
disposition: 0

Shared power to dispose or direct the disposition: 8,571,739

(3)      Deerfield Private Design Fund IV

Sole power to vote or direct the vote:
0

Shared power to vote or direct the vote:
8,545,652

Sole power to dispose or to direct the
disposition: 0

Shared power to dispose or direct the disposition: 8,545,652

(4)      Flynn

Sole power to vote or direct the vote:
0

Shared power to vote or direct the vote:
8,571,739

Sole power to dispose or to direct the
disposition: 0

Shared power to dispose or direct the disposition: 8,571,739

(4)      Hochberg

Sole power to vote or direct the vote:
0

Shared power to vote or direct the vote:
6,045,652

Sole power to dispose or to direct the
disposition: 0

Shared power to dispose or direct the disposition: 6,045,652

Flynn is the sole member of the general
partner of each of Deerfield Mgmt IV and Deerfield Management. Deerfield Mgmt IV is the general partner, and Deerfield Management
is the investment manager, of Deerfield Private Design Fund IV. Hochberg, an employee of Deerfield Management and a director of
the Company, also serves as Deerfield Private Design Fund IV’s designee on the board of managers of the Sponsor, which consists
of two managers.

Each Reporting Person may be deemed to
be a member of a “group” for purposes of the Securities Exchange Act of 1934 with the Sponsor and RAB Ventures (DFB)
LLC (“RAB”) (the other member of the Sponsor), and Richard Barasch. The Reporting Persons, the Sponsor, RAB and Mr.
Barasch may be deemed to collectively beneficially own an aggregate of 8,571,739 shares of Common Stock, or 27.43% of the issued
and outstanding shares of Common Stock. The share ownership reported for the Reporting Persons does not include any shares of Common
Stock held by the other member of the Sponsor or Mr. Barasch. Each Reporting Person disclaims beneficial ownership of any shares
of Common Stock beneficially owned by the other member of the Sponsor, except with respect to the shares owned by the Sponsor as
disclosed in this Schedule 13D.

(c) Except as set forth in Items 3 and
4 of this Schedule 13D, the Reporting Persons have not engaged in any transactions in the Company’s securities during the
past 60 days.

Follow Adapthealth Corp.

Page 9 of 10